LENZ Therapeutics Inc’s filing revealed that its 10% Owner Versant Venture Capital VI, L. unloaded Company’s shares for reported $6.51 million on Jul 10 ’25. In the deal valued at $34.00 per share,191,376 shares were sold. As a result of this transaction, Versant Venture Capital VI, L. now holds 1,575,899 shares worth roughly $51.61 million.
Then, Versant Venture Capital VI, L. sold 200,000 shares, generating $6,093,000 in total proceeds. Upon selling the shares at $30.46, the 10% Owner now owns 1,767,275 shares.
Before that, Versant Venture Capital VI, L. sold 133,924 shares. LENZ Therapeutics Inc shares valued at $4,051,201 were divested by the 10% Owner at a price of $30.25 per share. As a result of the transaction, Versant Venture Capital VI, L. now holds 1,967,275 shares, worth roughly $64.43 million.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Raymond James began covering LENZ with “an Outperform” recommendation on September 27, 2024. H.C. Wainwright started covering the stock on August 12, 2024. It rated LENZ as “a Buy”.
Price Performance Review of LENZ
On Tuesday, LENZ Therapeutics Inc [NASDAQ:LENZ] saw its stock fall -2.91% to $32.75. Over the last five days, the stock has gained 4.43%. LENZ Therapeutics Inc shares have risen nearly 67.01% since the year began. Nevertheless, the stocks have risen 13.44% over the past one year. While a 52-week high of $38.93 was reached on 07/11/25, a 52-week low of $16.53 was recorded on 04/09/25.
Levels Of Support And Resistance For LENZ Stock
The 24-hour chart illustrates a support level at 31.68, which if violated will result in even more drops to 30.62. On the upside, there is a resistance level at 34.01. A further resistance level may holdings at 35.27.
How much short interest is there in LENZ Therapeutics Inc?
A steep rise in short interest was recorded in LENZ Therapeutics Inc stocks on 2025-06-13, growing by 23836.0 shares to a total of 3.4 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 3.38 million shares. There was a rise of 0.7%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 15, 2024 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating .
